PROSPECTS AND OPPORTUNITIES
Rising incidence of back pain to stimulate use of analgesics
Analgesics in the United Arab Emirates is projected to see a moderate retail value (constant 2025 prices) CAGR over the forecast period. Media reports highlight a growing prevalence of back pain among residents in the United Arab Emirates, with back and joint issues emerging as leading causes of workplace absenteeism.
Strong advances in consumer health to bring benefits for analgesics
The United Arab Emirates has made strong advances in consumer health. In 2024, Haleon, the GBO of Panadol, developed an AI-powered tool called the Health Inclusivity Screener.
Search for better understanding of pain relief
The rise in health and wellness, and growing demand for analgesics, in the United Arab Emirates is partly driven by the need to educate a diverse population. With residents from a wide range of cultural and medical backgrounds, there is often no shared understanding of product categories like analgesics.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in United Arab Emirates with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in United Arab Emirates, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in United Arab Emirates report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in United Arab Emirates?
- Which are the leading brands in Analgesics in United Arab Emirates?
- How are products distributed in Analgesics in United Arab Emirates?
- How has the regulatory and operating environment for Analgesics changed in United Arab Emirates?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in the United Arab Emirates - Category analysis
KEY DATA FINDINGS
Wider use boosts analgesics
Panadol consolidates its clear leadership of analgesics
Pharmacies lead but there is a wide choice of channels for consumers of analgesics
Rising incidence of back pain to stimulate use of analgesics
Strong advances in consumer health to bring benefits for analgesics
Search for better understanding of pain relief
Consumer Health in the United Arab Emirates - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!